Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Publish
Dashboard
Subscribe to $IMMU
Immunomedics, Inc.
Subscribe to $IMMU
$IMMU
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Health Care
IPO Year: n/a
Exchange: NASDAQ
Recent Analyst Ratings for Immunomedics, Inc.
Date
Price Target
Rating
Analyst
See more ratings